Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03PIR
|
|||
| Former ID |
DIB011754
|
|||
| Drug Name |
Ceftezole
|
|||
| Synonyms |
ceftezole sodium; 41136-22-5; Falomesin; Celoslin; Alomen; UNII-3NHZ4Y117H; 3NHZ4Y117H; Ceftezole sodium [JAN]; Ceftezole Sodium (JAN); DSSTox_CID_28520; DSSTox_RID_82792; DSSTox_GSID_48594; Sodium (6R,7R)-3-(((1,3,4-thiadiazol-2-yl)thio)methyl)-7-(2-(1H-tetrazol-1-yl)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 8-oxo-7-((1H-tetrazol-1-ylacetyl)amino)-3-((1,3,4-thiadiazol-2-ylthio)methyl)-, monosodium salt, (6R-trans)-; CAS-41136-22-5
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Urinary tract infection [ICD-11: GC08; ICD-10: N39, N39.0; ICD-9: 599] | Approved | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H12N8O4S3
|
|||
| Canonical SMILES |
C1C(=C(N2C(S1)C(C2=O)NC(=O)CN3C=NN=N3)C(=O)O)CSC4=NN=CS4
|
|||
| InChI |
1S/C13H12N8O4S3/c22-7(1-20-4-14-18-19-20)16-8-10(23)21-9(12(24)25)6(2-26-11(8)21)3-27-13-17-15-5-28-13/h4-5,8,11H,1-3H2,(H,16,22)(H,24,25)/t8-,11-/m1/s1
|
|||
| InChIKey |
DZMVCVMFETWNIU-LDYMZIIASA-N
|
|||
| CAS Number |
CAS 26973-24-0
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:135716
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.